 |
|
|
|
Our Principal Research Center
 IndiPharm’s principal research facility is the Bombay Bioresearch Centre (BBRC),
located in Mumbai, India’s financial and medical capital. BBRC is a state of the art facility with core competency in GCP and GMP requirements, and is compliant with the requirements of FDA (U.S.), MHRA (U.K.), ANVISAQ (Brazil), Ministry of Health (Turkey), World Health Organization (Geneva, Switzerland), MCC (South Africa) and DCG (India).
With a total clinical research area of 33,000 square feet, BBRC houses a 72 bed clinical pharmacology unit, an in-house clinical laboratory with state of the art instruments, and a qualified, trained and experienced technical team.
BBRC has established strong relationships with nationally and internationally recognized physicians and clinical investigators, and has created a nationwide network of clinical trial
sites that are GCP compliant, have IRBs in place, and offer IFCC compliant laboratories
 with access to a common laboratory network. Most of these sites are routinely audited by a wide range of organizations. Each site meets the needs of global clinical trials and each is very “recruitment-friendly.” Over 90% of the investigators at these sites are either U.S. or U.K. trained and most are U.S. Board certified, with many having substantial experience in conducting global clinical trials.
|
|
|
|
|
|
